Effect of automatic positive airway pressure (APAP) therapy on blood pressure (BP) in patients with obstructive sleep apnea (OSA) and hypertension Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008
Early changes in blood pressure, vascular and heart function in obstructive sleep apnoea (OSA). Impact of treatment Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment Year: 2007
Pulmonary arterial hypertension (PAH) in patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2002; 20: Suppl. 38, 562s Year: 2002
Effects of treatments with nCPAP on cerebral blood flow velocity in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea Year: 2009
Effects of continuous positive airways pressure (CPAP) on portal flow in patients with obstructive apnoea syndrome (OSAS) Source: Eur Respir J 2007; 30: Suppl. 51, 321s Year: 2007
Management of hypertension in obstructive sleep apnoea: predicting blood pressure reduction under continuous positive airway pressure Source: Eur Respir J, 50 (4) 1701822; 10.1183/13993003.01822-2017 Year: 2017
Influence of continuous positive airway pressure therapy on endothelial function and blood pressure in patients with arterial hypertension and obstructive sleep apnoea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 814s Year: 2006
Prediction of effective continuous positive airway pressure (CPAP) in obstructive sleep apnea syndrome (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 111s Year: 2005
The need of higher CPAP pressure in a population with obstructive sleep apnea (OSA) and refractory hypertension (RHT) versus controlled hypertension-a retrospective study Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012
Evaluation of a polygraph based on peripheral arterial tone for the diagnosis of obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2004; 24: Suppl. 48, 571s Year: 2004
Recommendations for the management of patients with obstructive sleep apnoea and hypertension Source: Eur Respir J 2013; 41: 523-538 Year: 2013
Automated office blood pressure measurement increases prevalence of masked hypertension in patients with obstructive sleep apnoea Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification Year: 2020
Catecholamines and obstructive sleep apnea (OSA) severity: response to positive airway pressure (PAP) therapy Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2009
CPAP treatment reduce blood pressure in patients with recent diagnosis of systemic hypertension and obstructive sleep apnoea -hypopnoea (OSAH). A controlled study Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008
Circadian rhythm of systemic blood pressure in men with obstructive sleep apnoea syndrome ( OSAS ) Source: Eur Respir J 2001; 18: Suppl. 33, 89s Year: 2001
At 68 years, unrecognised sleep apnoea is associated with elevated ambulatory blood pressure}, Source: Eur Respir J 2012; 40: 649-656 Year: 2012
Relationship between obstructive sleep apnea syndrome (OSAS) and obesity, cholesterol disorders, blood pressure, and anatomical alterations Source: Eur Respir J 2006; 28: Suppl. 50, 817s Year: 2006
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA) Source: Sleep and Breathing Conference 2021 Year: 2021
Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients Source: Eur Respir J 2006; 27: 1229-1235 Year: 2006
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA). Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea Year: 2020